These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 27556694)

  • 21. The milk-derived lactoferrin inhibits V-ATPase activity by targeting its V1 domain.
    Santos-Pereira C; Rocha JF; Fernandes HS; Rodrigues LR; Côrte-Real M; Sousa SF
    Int J Biol Macromol; 2021 Sep; 186():54-70. PubMed ID: 34237360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of the vacuolar ATPase induces Bnip3-dependent death of cancer cells and a reduction in tumor burden and metastasis.
    Graham RM; Thompson JW; Webster KA
    Oncotarget; 2014 Mar; 5(5):1162-73. PubMed ID: 24811485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. V-ATPase is a candidate therapeutic target for Ewing sarcoma.
    Avnet S; Di Pompo G; Lemma S; Salerno M; Perut F; Bonuccelli G; Granchi D; Zini N; Baldini N
    Biochim Biophys Acta; 2013 Aug; 1832(8):1105-16. PubMed ID: 23579072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The proton pump inhibitor inhibits cell growth and induces apoptosis in human hepatoblastoma.
    Morimura T; Fujita K; Akita M; Nagashima M; Satomi A
    Pediatr Surg Int; 2008 Oct; 24(10):1087-94. PubMed ID: 18712525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intracellular pH regulation in U937 human monocytes: roles of V-ATPase and Na+/H+ exchange.
    Heming TA; Bidani A
    Immunobiology; 2003; 207(2):141-8. PubMed ID: 12675272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibitors of vacuolar ATPase proton pumps inhibit human prostate cancer cell invasion and prostate-specific antigen expression and secretion.
    Michel V; Licon-Munoz Y; Trujillo K; Bisoffi M; Parra KJ
    Int J Cancer; 2013 Jan; 132(2):E1-10. PubMed ID: 22945374
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glucose activates H(+)-ATPase in kidney epithelial cells.
    Nakamura S
    Am J Physiol Cell Physiol; 2004 Jul; 287(1):C97-105. PubMed ID: 15189820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Function of a subunit isoforms of the V-ATPase in pH homeostasis and in vitro invasion of MDA-MB231 human breast cancer cells.
    Hinton A; Sennoune SR; Bond S; Fang M; Reuveni M; Sahagian GG; Jay D; Martinez-Zaguilan R; Forgac M
    J Biol Chem; 2009 Jun; 284(24):16400-16408. PubMed ID: 19366680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Electrophysiological characterization of ATPases in native synaptic vesicles and synaptic plasma membranes.
    Obrdlik P; Diekert K; Watzke N; Keipert C; Pehl U; Brosch C; Boehm N; Bick I; Ruitenberg M; Volknandt W; Kelety B
    Biochem J; 2010 Mar; 427(1):151-9. PubMed ID: 20100168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Iejimalides A and B inhibit lysosomal vacuolar H+-ATPase (V-ATPase) activity and induce S-phase arrest and apoptosis in MCF-7 cells.
    McHenry P; Wang WL; Devitt E; Kluesner N; Davisson VJ; McKee E; Schweitzer D; Helquist P; Tenniswood M
    J Cell Biochem; 2010 Mar; 109(4):634-42. PubMed ID: 20039309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myrtenal-induced V-ATPase inhibition - A toxicity mechanism behind tumor cell death and suppressed migration and invasion in melanoma.
    Martins BX; Arruda RF; Costa GA; Jerdy H; de Souza SB; Santos JM; de Freitas WR; Kanashiro MM; de Carvalho ECQ; Sant'Anna NF; Antunes F; Martinez-Zaguilan R; Souad S; Okorokova-Façanha AL; Façanha AR
    Biochim Biophys Acta Gen Subj; 2019 Jan; 1863(1):1-12. PubMed ID: 30279148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The dual mechanism of the antifungal effect of new lysosomotropic agents on the Saccharomyces cerevisiae RXII strain.
    Krasowska A; Chmielewska L; Łuczyński J; Witek S; Sigler K
    Cell Mol Biol Lett; 2003; 8(1):111-20. PubMed ID: 12655364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel inhibitor of vacuolar ATPase, FR167356, which can discriminate between osteoclast vacuolar ATPase and lysosomal vacuolar ATPase.
    Niikura K; Takano M; Sawada M
    Br J Pharmacol; 2004 Jun; 142(3):558-66. PubMed ID: 15148249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. V-ATPase promotes transforming growth factor-β-induced epithelial-mesenchymal transition of rat proximal tubular epithelial cells.
    Cao X; Yang Q; Qin J; Zhao S; Li X; Fan J; Chen W; Zhou Y; Mao H; Yu X
    Am J Physiol Renal Physiol; 2012 May; 302(9):F1121-32. PubMed ID: 22129967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacologic inhibition of vacuolar H+ ATPase reduces physiologic and oncogenic Notch signaling.
    Kobia F; Duchi S; Deflorian G; Vaccari T
    Mol Oncol; 2014 Mar; 8(2):207-20. PubMed ID: 24309677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasmalemmal V-ATPase as a Potential Biomarker for Lactoferrin-Based Anticancer Therapy.
    Santos-Pereira C; Rodrigues LR; Côrte-Real M
    Biomolecules; 2022 Jan; 12(1):. PubMed ID: 35053267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Osteoclast proton pump regulator Atp6v1c1 enhances breast cancer growth by activating the mTORC1 pathway and bone metastasis by increasing V-ATPase activity.
    McConnell M; Feng S; Chen W; Zhu G; Shen D; Ponnazhagan S; Deng L; Li YP
    Oncotarget; 2017 Jul; 8(29):47675-47690. PubMed ID: 28504970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vacuolar H+ ATPase expression and activity is required for Rab27B-dependent invasive growth and metastasis of breast cancer.
    Hendrix A; Sormunen R; Westbroek W; Lambein K; Denys H; Sys G; Braems G; Van den Broecke R; Cocquyt V; Gespach C; Bracke M; De Wever O
    Int J Cancer; 2013 Aug; 133(4):843-54. PubMed ID: 23390068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A vacuolar ATPase inhibitor, FR167356, prevents bone resorption in ovariectomized rats with high potency and specificity: potential for clinical application.
    Niikura K; Takeshita N; Takano M
    J Bone Miner Res; 2005 Sep; 20(9):1579-88. PubMed ID: 16059630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isoform-specific gene disruptions reveal a role for the V-ATPase subunit a4 isoform in the invasiveness of 4T1-12B breast cancer cells.
    McGuire CM; Collins MP; Sun-Wada G; Wada Y; Forgac M
    J Biol Chem; 2019 Jul; 294(29):11248-11258. PubMed ID: 31167791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.